Latest Breaking News On - American heart association council on hypertension - Page 4 : comparemela.com

May 25, 2021 With all events adjudicated, intensive blood pressure-lowering remains superior to standard control when it comes to reducing adverse clinical outcomes in nondiabetic patients at high cardiovascular risk, with that benefit accompanied by higher risks of some serious adverse events, including hypotension, electrolyte abnormalities, acute kidney injury/failure, and syncope, final results of the SPRINT trial show. When the initial trial results were released in November 2015, investigators had not yet been able to adjudicate all potential outcome events that occurred during the intervention period because the study was stopped early. In addition, they had not yet collected or analyzed data after the intervention period ended.

United statesVivek bhallaCora lewisMd stanford university school of medicineMd university of alabama at birminghamAmerican heart association council on hypertensionNew england journalStanford university schoolAmerican heart associationKidney diseaseImproving global outcomesஒன்றுபட்டது மாநிலங்களில்விவேக் பல்லாகோரா லெவிஸ்ம்ட் ஸ்டான்போர்ட் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்தும்ட் பல்கலைக்கழகம் ஆஃப் அலபாமா இல் பர்மிங்காம்